Stock Research

OpenAI, the creator of ChatGPT, is on track to raise billions of dollars from its existing and new investors, a sign that the artificial intelligence (AI) boom is accelerating. OpenAI to raise billions as competition rises  The latest reporting by The Information shows that the company is about to raise as much as $100 billion… Continue reading OpenAI eyes billions in funding from tech giants Amazon, NVIDIA, Microsoft, Softbank

Nvidia stock rose early on Wednesday as investors welcomed signs of progress in the company’s access to the Chinese market, easing a key overhang that has weighed on the stock for months. Optimism around continued funding momentum for artificial intelligence development, including potential capital backing for ChatGPT-developer OpenAI, also supported sentiment toward the chipmaker. Nvidia… Continue reading Nvidia stock in the green after China chip approval reports: can it keep going higher?

Palladyne AI (NASDAQ: PDYN) soared nearly 50% this morning after announcing a new contract with the US Air Force Research Laboratory (AFRL). The contract is for a project titled “Hierarchical Adaptive Networked Game-Theoretic Integration of Multiple Echelons” or simply “HANGTIME”. According to PDYN’s press release, this initiative aims at solving a critical bottleneck in modern… Continue reading Palladyne stock: 3 big reasons to sell it on Air Force contract rally

Tesla stock (NASDAQ: TSLA) ticked higher in early Wednesday trading as investors positioned ahead of the company’s fourth-quarter 2025 earnings results due after the market closing. The call carries outsized weight because Wall Street consensus has shifted from fixating on vehicle deliveries to scrutinizing progress on artificial intelligence, robotaxi deployment, and a software subscription business.… Continue reading Tesla stock moves higher ahead of Q4 earnings: analysts weigh in

Wedbush Securities’ senior analyst Dan Ives recommends sticking with Apple (NASDAQ: AAPL) ahead of its Q1 earnings on January 29th. The tech titan is broadly expected to post a nearly 11% increase in revenue to $138.47 billion – its largest year-on-year growth since 2022 – on the back of strong iPhone 17 demand. AAPL’s earnings… Continue reading Apple Q1 earnings preview: Wedbush continues to see AAPL as ‘top pick’

Europe’s fault lines are widening as leaders, markets, and central banks grapple with a more hostile global order. From Keir Starmer’s delicate China outreach under Washington’s glare to Germany’s faltering growth despite massive spending promises, the continent’s economic engine is sputtering. Corporate bright spots like ASML’s AI-fueled boom contrast sharply with policy anxiety, as a… Continue reading Europe bulletin: Starmer courts China, ASML surges on AI, Germany’s growth stalls

European stocks are finally showing signs of life, with analysts at UBS highlighting a stronger and more reliable earnings backdrop than investors have seen in years. With valuations still trading at a discount compared to US peers, the stage is set for select European names to deliver outsized returns. To UBS experts, two stand out… Continue reading Looking for 50% plus return in 2026? Buy these 2 European stocks today

Bitcoin is stuck in a tight band ahead of this week’s Federal Reserve decision, with several analysts flagging a potential Wyckoff “spring” that could push prices below $80,000 before momentum rebuilds. Flows and positioning remain skewed by US institutions, while safe-haven assets surge and macro uncertainty rises. Bitcoin holds range as event risk builds Bitcoin… Continue reading Bitcoin faces Fed test as analysts warn of possible dip below $80,000

The Trump administration delivered a stunning blow to health insurers, proposing a near-flat 0.09% payment increase for Medicare Advantage plans next year, far below Wall Street’s expectations of 4 to 6%. The decision triggered an immediate stock market rout: Humana plunged 13 to 20%, UnitedHealth and CVS each fell roughly 10 to 19%, erasing approximately… Continue reading Medicare shock: health insurers could cut benefits for 35M seniors in 2027- here’s why